Whether you're launching new products or switching suppliers, Inbiose delivers high-purity HMOs with unmatched cost-effiency, flexible minimal order quantity (MOQ), and industry-leading innovation.
Get technical data, pricing & regulatory info fast or book a call with our HMO experts.
Human Milk Oligosaccharides (HMOs) are complex, non-digestible carbohydrates found naturally in breast milk. After lactose and lipids, they are the third most abundant solid component, with over 200 unique structures identified to date.
HMOs are designed by nature to directly and indirectly support gut health, immune function, metabolic and microbial balance, while barely being digested by the human body.
Our Human Milk Oligosaccharides (HMOs) mimic the complex sugars in human breastmilk — shown to support immunity, gut microbiota, and metabolic health in infants, adults and animals.
Our Human Milk Oligosaccharides (HMOs) mimic the complex sugars in human breastmilk — shown to support immunity, gut microbiota, and metabolic health in infants, adults and animals.
Our Human Milk Oligosaccharides (HMOs) mimic the complex sugars in human breastmilk — shown to support immunity, gut microbiota, and metabolic health in infants, adults and animals.
Our Human Milk Oligosaccharides (HMOs) mimic the complex sugars in human breastmilk — shown to support immunity, gut microbiota, and metabolic health in infants, adults and animals.
Human Milk Oligosaccharides (HMOs) are complex carbohydrates naturally found in breast milk. HMOs are the third most abudant solid ingredient in breast milk, following lactose and lipids. Barely absorbed, and not digested by the infant, HMOs reach the colon intact. They nourish beneficial gut bacteria, block harmful microbes, and support the developing immune system. Research shows that HMOs also contribute to gut barrier function and early cognitive development, making them essential to infant health.
Absolutely. HMOs are highly versatile and can be used in sport drinks, yoghurts, infant formula, gummies, sachets, bars, capsules, and more. They offer a mild sweet taste and high heat stability, making them ideal for product innovation. Regulatory status and labeling requirements vary by region, so it is advised to consult our experts for tailored guidance.
Yes, HMOs are increasingly researched and formulated for adults, pets, livestock, and broader populations. While inspired by breast milk, specific HMOs can support gut health, immune regulation, and metabolic balance across age groups. Clinical and internal studies confirm their excellent safety profile, consistent with the fact that newborns naturally consume large quantities of HMOs.
HMOs are produced without using breast milk. Scientists design safe bacteria, similar to those used for making vitamins or enzymes, to ferment and create HMOs. Once fermentation is complete, the mixture is purified to remove the bacteria, yielding a clean, high-purity HMO that’s chemically identical to those found in breast milk. The result is safe, scalable, and ready for food and health applications.
While pregnant, women already start producing HMOs as early as the first trimester. There is great variability in quantity of individual HMOs that is produced in different women, and throughout the lactation period. One of the major differences is determined by genetics in the FUT2 gene: secretor vs non-secretor of 2'-FL.
Graph adapted from
Liu et al., 2023
Graph adapted from
Liu et al., 2023
Graph representing a non-secretor group (12%) from a US cohort, adapted from Plows et al., 2021